Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
JCO Precision Oncology|February 9, 2022
Phase I Trial of Dabrafenib and Pazopanib in <i>BRAF</i> Mutated Advanced MalignanciesSigurdis Haraldsdottir, Filip Janku, Ming Poi, et al.
The Lancet. Oncology|August 21, 2019
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 studyMoshe C Ornstein, Sumanta K Pal, Laura S Wood, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 16, 2019
<sup>18</sup>F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumabIlhan Lim, Maria Liza Lindenberg, Esther Mena, et al.
American Journal of Clinical Oncology|January 8, 2021
Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor TherapyAnish B Parikh, Xiaobo Zhong, George Mellgard, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2021
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignanciesKatharine A Collier, Hugo Valencia, Herbert Newton, et al.
Laryngoscope Investigative Otolaryngology|October 20, 2021
Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomasD Bradley Welling, Katharine A Collier, Sarah S Burns, et al.
Cancers|May 25, 2024
Characterization of <i>FOLH1</i> Expression in Renal Cell CarcinomaEric Ovruchesky, Elizabeth Pan, Melis Guer, et al.
JAMA Oncology|August 26, 2021
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical TrialSumanta K Pal, Paul H Frankel, Amir Mortazavi, et al.
Cancer|November 20, 2020
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignanciesBradley Alexander McGregor, Matthew T Campbell, Wanling Xie, et al.
Investigational New Drugs|August 1, 2012
A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumorsAmir Mortazavi, Yonghua Ling, Ludmila Katherine Martin, et al.
Pageof 9